Melola Discovery

← Melola Discovery

Jurnal SINTA 1

The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease

ACTA MEDICA INDONESIANA · Vol. 49 No. 3 (2017)

ISSN
2338-2732, 0125-9326
Terbit
2017-11-02
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

Background: graves’ disease (GD) is the most common condition of thyrotoxicosis. The management of GD is initiated with the administration of antithyroid drugs; however, it requires a long time to achieve remission. In reality more than 50% of patients who had remission may be at risk for relapse after the drug is stopped. This study aimed to evaluate the role of clinical factors such as smoking habit, degree of ophtalmopathy, degree of thyroid enlargement; genetic factors such as CTLA-4 gene on nucleotide 49 at codon 17 of exon 1, CTLA-4 gene of promotor -318, TSHR gene polymorphism rs2268458 of intron 1; and immunological factors such as regulatory T cells (Treg) and thyroid receptor antibody (TRAb); that affecting the relapse of patients with Graves’ disease in Indonesia. Methods: this was a case-control study, that compared 72 subjects who had relapse and 72 subjects without relapse at 12 months after cessation of antithyroid treatment, who met the inclusion criteria. Genetic polymorphism examination was performed using PCR-RFLP. The number of regulatory T cells was counted using flow cytometry analysis and ELISA was used to measure TRAb. The logistic regression was used since the dependent variables were categorical variables. Results: the analysis of this study demonstrated that there was a correlation between relapse of disease and family factors (p=0.008), age at diagnosis (p=0.021), 2nd degree of Graves’ ophthalmopathy (p=0.001), enlarged thyroid gland, which exceeded the lateral edge of the sternocleidomastoid muscles (p=0.040), duration of remission period (p=0.029), GG genotype of CTLA-4 gene on the nucleotide 49 at codon 17 of exon 1 (p=0.016), CC genotype of TSHR gene on the rs2268458 of intron 1 (p=0.003), the number of regulatory T cells (p=0.001) and TRAb levels (p=0.002). Conclusion: genetic polymorphisms of CTLA-4 gene on the nucleotide 49 at codon 17 of exon 1, TSHR gene SNP rs2268458 of intron 1, number of regulatory T cells and TRAb levels play a role as risk factors for relapse in patients with Graves’ disease.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 140 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Alvina WidhaniAfiliasi tidak diketahui3
Pradana SoewondoAfiliasi tidak diketahui3
Iris RengganisAfiliasi tidak diketahui2
Anshari Saifuddin HasibuanAfiliasi tidak diketahui2
Sukamto KoesnoeAfiliasi tidak diketahui2
Suzy MariaAfiliasi tidak diketahui2
Nafrialdi NafrialdiAfiliasi tidak diketahui2
Heri NugrohoAfiliasi tidak diketahui2
Dyah PurnamasariAfiliasi tidak diketahui1
Starry H RampenganAfiliasi tidak diketahui1
Minarma SiagianAfiliasi tidak diketahui1
Suzanna ImmanuelAfiliasi tidak diketahui1
M. KurniawanAfiliasi tidak diketahui1
Salim HarrisAfiliasi tidak diketahui1
Deddy HermawanAfiliasi tidak diketahui1
Syafruddin IlyasAfiliasi tidak diketahui1
Silvia W LestariAfiliasi tidak diketahui1
Nukman MoeloekAfiliasi tidak diketahui1
Siregar C SiregarAfiliasi tidak diketahui1
Muchtaruddin MansyurAfiliasi tidak diketahui1
Cosphiadi IrawanAfiliasi tidak diketahui1
Djumhana AtmakusumahAfiliasi tidak diketahui1
Abdulmuthalib AbdulmuthalibAfiliasi tidak diketahui1
Nurjati Chaeranie SiregarAfiliasi tidak diketahui1
The Bin TeanAfiliasi tidak diketahui1
Lim Weng KongAfiliasi tidak diketahui1
Ong Choon KiatAfiliasi tidak diketahui1
Siti SetiatiAfiliasi tidak diketahui1
Tirza Z TaminAfiliasi tidak diketahui1
Purwita Wijaya LaksmiAfiliasi tidak diketahui1
Wasilah RochmahAfiliasi tidak diketahui1
Ridho NaibahoAfiliasi tidak diketahui1
Maretina W WiyatiAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors  for Relapse in Patients with Graves Disease</dc:title>
	<dc:creator>Eliana, Fatimah</dc:creator>
	<dc:creator>Suwondo, Pradana</dc:creator>
	<dc:creator>Asmarinah, Asmarinah</dc:creator>
	<dc:creator>Harahap, Alida</dc:creator>
	<dc:creator>Djauzi, Samsuridjal</dc:creator>
	<dc:creator>Prihartono, Joedo</dc:creator>
	<dc:creator>Pemayun, Tjokorda Gde Dalem</dc:creator>
	<dc:subject xml:lang="en-US">graves’ disease</dc:subject>
	<dc:subject xml:lang="en-US">relapse</dc:subject>
	<dc:subject xml:lang="en-US">CTLA-4 gene exon 1</dc:subject>
	<dc:subject xml:lang="en-US">CTLA-4 gene with promotor-318</dc:subject>
	<dc:subject xml:lang="en-US">TSHR gene rs2268458 intron 1</dc:subject>
	<dc:subject xml:lang="en-US">Regulatory T cells</dc:subject>
	<dc:subject xml:lang="en-US">Thyroid Receptor Antibody (TRAb)</dc:subject>
	<dc:description xml:lang="en-US">Background: graves’ disease (GD) is the most common condition of thyrotoxicosis. The management of GD is initiated with the administration of antithyroid drugs; however, it requires a long time to achieve remission. In reality more than 50% of patients who had remission may be at risk for relapse after the drug is stopped. This study aimed to evaluate the role of clinical factors such as smoking habit, degree of ophtalmopathy, degree of thyroid enlargement; genetic factors such as CTLA-4 gene on nucleotide 49 at codon 17 of exon 1, CTLA-4 gene of promotor -318, TSHR gene polymorphism rs2268458 of intron 1; and immunological factors such as regulatory T cells (Treg) and thyroid receptor antibody (TRAb); that affecting the relapse of patients with Graves’ disease in Indonesia. Methods: this was a case-control study, that compared 72 subjects who had relapse and 72 subjects without relapse at 12 months after cessation of antithyroid treatment, who met the inclusion criteria. Genetic polymorphism examination was performed using PCR-RFLP. The number of regulatory T cells was counted using flow cytometry analysis and ELISA was used to measure TRAb. The logistic regression was used since the dependent variables were categorical variables. Results: the analysis of this study demonstrated that there was a correlation between relapse of disease and family factors (p=0.008), age at diagnosis (p=0.021), 2nd degree of Graves’ ophthalmopathy (p=0.001), enlarged thyroid gland, which exceeded the lateral edge of the sternocleidomastoid muscles (p=0.040), duration of remission period (p=0.029), GG genotype of CTLA-4 gene on the nucleotide 49 at codon 17 of exon 1 (p=0.016), CC genotype of TSHR gene on the rs2268458 of intron 1 (p=0.003), the number of regulatory T cells (p=0.001) and TRAb levels (p=0.002). Conclusion: genetic polymorphisms of CTLA-4 gene on the nucleotide 49 at codon 17 of exon 1, TSHR gene SNP rs2268458 of intron 1, number of regulatory T cells and TRAb levels play a role as risk factors for relapse in patients with Graves’ disease.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2017-11-02</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/340</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 49 No. 3 (2017): Acta Medica Indonesiana; 195</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/340/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Acta Medica Indonesiana</dc:rights>
</oai_dc:dc>